Related Experiment Videos
Ganglioside loss is a primary event in Alzheimer disease type I
1Department of Clinical Neuroscience, Section of Psychiatry and Neurochemistry, University of Göteborg, Sweden.
Progress in Brain Research
|January 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Intracerebroventricular administration of GM1 ganglioside to presenile Alzheimer patients.
Dementia and geriatric cognitive disorders·1997
Membrane components separate early-onset Alzheimer's disease from senile dementia of the Alzheimer type.
International psychogeriatrics·1996
Reductions in membrane proteins and lipids in basal ganglia of classic Alzheimer disease patients.
Alzheimer disease and associated disorders·1996
Gangliosides in children with autism.
Acta paediatrica (Oslo, Norway : 1992)·1995
REM sleep behavior disorder and synucleinopathies.
Progress in brain research·2026
Neurobiology of sleep apnea and cognitive impairment.
Progress in brain research·2026
Sleep, anxiety, and depression: The bidirectional brain-behavior axis.
Progress in brain research·2026
Neuromodulation in sleep disorders.
Progress in brain research·2026
Insomnia phenotypes and neurocognitive biomarkers.
Progress in brain research·2026
Isolated atrial amyloidosis from atrial natriuretic peptide - a common but overlooked cardiac condition.
Upsala journal of medical sciences·2026
Epigenetic reprogramming in autoimmune and immune-mediated skin disease.
Frontiers in immunology·2026